For: | Liao CS, Lin YM, Chang HC, Chen YH, Chong LW, Chen CH, Lin YS, Yang KC, Shih CH. Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia. World J Gastroenterol 2013; 19(45): 8366-8372 [PMID: 24363529 DOI: 10.3748/wjg.v19.i45.8366] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i45/8366.htm |
Number | Citing Articles |
1 |
J. S. Hunt, C. Cock, E. L. Symonds. A True Positive and a False Negative? The Dilemma of Negative Colonoscopy After a Positive Fecal Occult Blood Test. Digestive Diseases and Sciences 2022; 67(5): 1843 doi: 10.1007/s10620-021-06986-4
|
2 |
Chan Hyuk Park, Yoon Suk Jung, Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn. Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factors. Gastrointestinal Endoscopy 2019; 89(6): 1204 doi: 10.1016/j.gie.2019.02.023
|
3 |
Emilie C. H. Breekveldt, Esther Toes‐Zoutendijk, Hilliene J. van de Schootbrugge‐Vandermeer, Lucie de Jonge, Arthur I. Kooyker, Manon C. W. Spaander, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian Ramakers, Evelien Dekker, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp‐Vogelaar. Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program. International Journal of Cancer 2023; 152(8): 1536 doi: 10.1002/ijc.34373
|
4 |
Meng‐Yu Chen, Hung‐Chuen Chang, Lee‐Won Chong, Yuh‐Hwa Liu, Cheuk‐Kay Sun, Kuo‐Ching Yang, Yu‐Min Lin. Relatively low risk and nonaggressive stage of colorectal cancer in individuals with negative baseline fecal immunochemical test results: A cohort study. Advances in Digestive Medicine 2021; 8(1): 19 doi: 10.1002/aid2.13169
|
5 |
H. Ghajari, A. Sadeghi, S. Khodakarim, M. Zali, S. S. Hashemi Nazari. Designing a Predictive Model for Colorectal Neoplasia Diagnosis Based on Clinical and Laboratory Findings in Colonoscopy Candidate Patients. Journal of Gastrointestinal Cancer 2022; 53(4): 880 doi: 10.1007/s12029-021-00737-4
|
6 |
Dae Ho Kim, Jae Myung Cha, Min Seob Kwak, Jin Young Yoon, Young-Hak Cho, Jung Won Jeon, Hyun Phil Shin, Kwang Ro Joo, Joung Il Lee. Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea. Gut and Liver 2018; 12(2): 183 doi: 10.5009/gnl17030
|
7 |
Po-Hsiang Ting, Xi-Hsuan Lin, Jeng-Kai Jiang, Jiing-Chyuan Luo, Ping-Hsien Chen, Yen-Po Wang, I-Fang Hsin, Chin Lin Perng, Ming-Chih Hou, Fa-Yauh Lee. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes. Journal of the Chinese Medical Association 2018; 81(9): 759 doi: 10.1016/j.jcma.2017.11.015
|
8 |
Yoon Suk Jung. Strategies for colorectal cancer screening and post-polypectomy surveillance for young adults under age 50. Precision and Future Medicine 2021; 5(2): 69 doi: 10.23838/pfm.2021.00051
|
9 |
Mercedes Navarro, Gonzalo Hijos, Teresa Ramirez, Ignacio Omella, Patricia Carrera-Lasfuentes, Ángel Lanas. Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00091
|
10 |
Sherry Yueh-Hsia Chiu, Shu-Ling Chuang, Sam Li-Sheng Chen, Amy Ming-Fang Yen, Jean Ching-Yuan Fann, Dun-Cheng Chang, Yi-Chia Lee, Ming-Shiang Wu, Chu-Kuang Chou, Wen-Feng Hsu, Shu-Ti Chiou, Han-Mo Chiu. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Gut 2017; 66(2): 293 doi: 10.1136/gutjnl-2015-310256
|
11 |
Ian M. Godber, Louise M. Todd, Callum G. Fraser, Linda R. MacDonald, Hakim Ben Younes. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms. Clinical Chemistry and Laboratory Medicine (CCLM) 2016; 54(4) doi: 10.1515/cclm-2015-0617
|
12 |
Josep M. Auge, Maria Pellise, José M. Escudero, Cristina Hernandez, Montserrat Andreu, Jaume Grau, Andrea Buron, María López-Cerón, Xavier Bessa, Anna Serradesanferm, Mercè Piracés, Francesc Macià, Rafael Guayta, Xavier Filella, Rafael Molina, Wladimiro Jimenez, Antoni Castells. Risk Stratification for Advanced Colorectal Neoplasia According to Fecal Hemoglobin Concentration in a Colorectal Cancer Screening Program. Gastroenterology 2014; 147(3): 628 doi: 10.1053/j.gastro.2014.06.008
|
13 |
James E. Allison, Callum G. Fraser, Stephen P. Halloran, Graeme P. Young. Colorectal Cancer Screening. 2015; : 65 doi: 10.1007/978-1-4939-2333-5_4
|
14 |
Hsin‐Yeh Yang, Yu‐Min Lin, Lee‐Won Chong, Hung‐Chuen Chang, Chao‐Sheng Liao, Kuo‐Ching Yang. Performance of quantitative immunochemical test for fecal hemoglobin for surveillance of colorectal neoplasia after polypectomy in clinical practice. Advances in Digestive Medicine 2017; 4(4): 128 doi: 10.1002/aid2.12128
|
15 |
Szu-Min Peng, Han-Mo Chiu, Hsiao-Hsuan Jen, Chen-Yang Hsu, Sam Li-Sheng Chen, Sherry Yueh-Hsia Chiu, Amy Ming-Fang Yen, Jean Ching-Yuan Fann, Yi-Chia Lee, Hsiu-Hsi Chen. Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees. BMC Medical Informatics and Decision Making 2019; 19(1) doi: 10.1186/s12911-019-0812-1
|
16 |
Christian Balamou, Akoï Koïvogui, Christelle M Rodrigue, Aurélie Clerc, Claire Piccotti, Anne Deloraine, Catherine Exbrayat. Prediction of the severity of colorectal lesion by fecal hemoglobin concentration observed during previous test in the French screening program. World Journal of Gastroenterology 2021; 27(31): 5272-5287 doi: 10.3748/wjg.v27.i31.5272
|
17 |
Omar Sharif, Afnan Freije, Salwa Al-Thawadi, Dalal Alromaihi, Fida Alsaffar, Essam Juma, Faisal Abubaker, Abdulrahman Barakat, Mariam Alhammadi, Zeyad Mahmood, Suha Hejres, Hanan Matar, Alice Trezza, Mariangela Rondanelli, Simone Perna. Exploring the Dietary, Lifestyle, and Demographic Factors Associated with Risk for Colorectal Cancer and Colorectal Abnormalities in a Fecal Immunochemical Test-Positive Population: A Cross-Sectional Study in the Kingdom of Bahrain. Gastrointestinal Disorders 2024; 6(3): 622 doi: 10.3390/gidisord6030041
|
18 |
Han-Mo Chiu, Li-Chun Chang, Wen-Feng Hsu, Chu-Kuang Chou, Ming-Shiang Wu. Non-invasive screening for colorectal cancer in Asia. Best Practice & Research Clinical Gastroenterology 2015; 29(6): 953 doi: 10.1016/j.bpg.2015.09.015
|
19 |
Nam Hee Kim, Min-Jung Kwon, Hyun-young Kim, Taeheon Lee, Seok Hyeon Jeong, Dong Il Park, Kyuyong Choi, Yoon Suk Jung. Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia. Digestive and Liver Disease 2016; 48(6): 667 doi: 10.1016/j.dld.2016.03.001
|
20 |
Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Lucie de Jonge, Manon C. W. Spaander, Evelien Dekker, Folkert J. van Kemenade, Anneke J. van Vuuren, Christian R. B. Ramakers, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT). BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02670-1
|
21 |
Montse Garcia. Addressing overuse and overdiagnosis in colorectal cancer screening for average-risk individuals. Colorectal Cancer 2015; 4(1): 27 doi: 10.2217/crc.15.4
|